Aerospace Composites Market
Description
Aerospace Composites Market Summary
The global aerospace composites market size was estimated at USD 1.54 billion in 2025 and is projected to reach USD 2.81 billion by 2033, expected to grow at a CAGR of 7.9% from 2026 to 2033. The demand for aerospace composites is increasing due to the aviation industry’s strong focus on lightweight materials that improve fuel efficiency and reduce carbon emissions.
Aircraft manufacturers are increasingly replacing traditional metals with composites to achieve weight reduction without compromising structural integrity. The growing production of commercial aircraft, driven by rising air passenger traffic globally, is further fueling demand. Defense modernization programs are also driving the adoption of advanced composite materials in military aircraft and UAVs. In addition, the rise in space exploration missions and satellite launches is boosting the use of high-performance aerospace composites. Airlines’ emphasis on lowering operating costs is encouraging OEMs to adopt composite-intensive aircraft platforms. Key drivers of the aerospace composites market include stringent fuel efficiency regulations and emission norms imposed by aviation authorities. Composites offer superior strength-to-weight ratios, corrosion resistance, and fatigue performance compared to metals. Increasing use of carbon fiber reinforced polymers (CFRP) in fuselage, wings, and interior components is a major growth driver. Technological advancements in resin systems and manufacturing processes such as automated fiber placement are accelerating adoption. Rising defense budgets across major economies are increasing procurement of advanced aircraft platforms. Growth in the aftermarket and MRO sector is also supporting demand for composite repair materials.
The aerospace composites market is witnessing strong innovation in thermoplastic composites due to their recyclability and faster processing times. Development of next-generation carbon fibers with improved strength and toughness is gaining traction. Automation and digital manufacturing technologies are transforming composite fabrication efficiency. Hybrid composites combining carbon, glass, and ceramic fibers are emerging for specialized applications. There is increasing focus on sustainable composite materials and recycling technologies. Advanced resin systems with enhanced fire, smoke, and toxicity resistance are being adopted. These trends are reshaping material selection and aircraft design strategies.
Global Aerospace Composites Market Report Segmentation
This report forecasts revenue growth at regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the aerospace composites market based on product, application, and region:
The global aerospace composites market size was estimated at USD 1.54 billion in 2025 and is projected to reach USD 2.81 billion by 2033, expected to grow at a CAGR of 7.9% from 2026 to 2033. The demand for aerospace composites is increasing due to the aviation industry’s strong focus on lightweight materials that improve fuel efficiency and reduce carbon emissions.
Aircraft manufacturers are increasingly replacing traditional metals with composites to achieve weight reduction without compromising structural integrity. The growing production of commercial aircraft, driven by rising air passenger traffic globally, is further fueling demand. Defense modernization programs are also driving the adoption of advanced composite materials in military aircraft and UAVs. In addition, the rise in space exploration missions and satellite launches is boosting the use of high-performance aerospace composites. Airlines’ emphasis on lowering operating costs is encouraging OEMs to adopt composite-intensive aircraft platforms. Key drivers of the aerospace composites market include stringent fuel efficiency regulations and emission norms imposed by aviation authorities. Composites offer superior strength-to-weight ratios, corrosion resistance, and fatigue performance compared to metals. Increasing use of carbon fiber reinforced polymers (CFRP) in fuselage, wings, and interior components is a major growth driver. Technological advancements in resin systems and manufacturing processes such as automated fiber placement are accelerating adoption. Rising defense budgets across major economies are increasing procurement of advanced aircraft platforms. Growth in the aftermarket and MRO sector is also supporting demand for composite repair materials.
The aerospace composites market is witnessing strong innovation in thermoplastic composites due to their recyclability and faster processing times. Development of next-generation carbon fibers with improved strength and toughness is gaining traction. Automation and digital manufacturing technologies are transforming composite fabrication efficiency. Hybrid composites combining carbon, glass, and ceramic fibers are emerging for specialized applications. There is increasing focus on sustainable composite materials and recycling technologies. Advanced resin systems with enhanced fire, smoke, and toxicity resistance are being adopted. These trends are reshaping material selection and aircraft design strategies.
Global Aerospace Composites Market Report Segmentation
This report forecasts revenue growth at regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the aerospace composites market based on product, application, and region:
- Product Outlook (Volume, Kilotons; Revenue, USD Billion, 2026 - 2033)
- Carbon Fiber
- Glass Fiber
- Other Products
- Application Outlook (Volume, Kilotons; Revenue, USD Billion, 2026 - 2033)
- Commercial Aircraft
- Military Aircraft
- Business & General Aviation
- Other Applications
- Regional Outlook (Volume, Kilotons; Revenue, USD Billion, 2026 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Latin America
- Brazil
- Middle East & Africa
Table of Contents
107 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Delivery Mode
- 1.1.4. Component
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline.
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Delivery mode outlook
- 2.2.4. Component outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Clinical Decision Support Systems Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising Adoption of Electronic Health Records (EHRs)
- 3.2.1.2. Increasing Demand for Quality Care and Patient Safety
- 3.2.1.3. Advancements in AI and Machine Learning Technologies
- 3.2.1.4. Supportive Government Initiatives and Healthcare IT Policies
- 3.2.1.5. Integration of CDSS with Clinical Workflows
- 3.2.1.6. Need to Reduce Medication Errors and Diagnostic Inaccuracies
- 3.2.1.7. Emergence of Cloud-Based CDSS Solutions
- 3.2.2. Market restraint analysis
- 3.2.2.1. High Implementation and Integration Costs
- 3.2.2.2. Data Privacy and Security Concerns
- 3.2.2.3. Interoperability Challenges with Legacy Systems
- 3.2.3. Technological Advancements & AI Integration
- 3.2.3.1. AI & Machine Learning Adoption: How AI is shaping CDSS capabilities.
- 3.2.3.2. Cloud-Based vs. On-Premise Solutions: Which deployment models are gaining traction
- 3.2.3.3. Interoperability & Integration: Compatibility with existing Electronic Health Records (EHRs) and hospital systems
- 3.2.4. Regulatory & Compliance Factors
- 3.2.4.1. FDA & HIPAA Regulations: Impact of compliance on market players
- 3.2.4.2. Data Privacy & Security Risks: Investor concerns about patient data protection
- 3.2.5. Case Study Insights
- 3.3. Clinical Decision Support Systems Market Analysis Tools
- 3.3.1. Industry Analysis – Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.2.4. Social landscape
- 3.3.2.5. Legal landscape
- Chapter 4. Clinical Decision Support Systems Market: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2025 & 2033
- 4.2. Segment Dashboard
- 4.3. Global Clinical Decision Support Systems Market by Product Outlook
- 4.4. Standalone CDSS
- 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.5. Integrated CPOE with CDSS
- 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.6. Integrated EHR with CDSS
- 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.7. Integrated CDSS with CPOE and HER
- 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
- Chapter 5. Clinical Decision Support Systems Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2025 & 2033
- 5.2. Segment Dashboard
- 5.3. Global Clinical Decision Support Systems Market by Application Outlook
- 5.4. Drug-Drug Interactions
- 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.5. Drug Allergy Alerts
- 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.6. Clinical Reminders
- 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.7. Clinical Guidelines
- 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.8. Drug Dosing Support
- 5.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.9. Others
- 5.9.1. Market estimates and forecast 2021 to 2033 (USD Million)
- Chapter 6. Clinical Decision Support Systems Market: Delivery Mode Estimates & Trend Analysis
- 6.1. Delivery Modes Market Share, 2025 & 2033
- 6.2. Segment Dashboard
- 6.3. Clinical Decision Support Systems Market by Delivery Modes Outlook
- 6.4. Web-Based Systems
- 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 6.5. Cloud-Based Systems
- 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 6.6. On-Premise Systems
- 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
- Chapter 7. Clinical Decision Support Systems Market: Component Estimates & Trend Analysis
- 7.1. Component Market Share, 2025 & 2033
- 7.2. Segment Dashboard
- 7.3. Clinical Decision Support Systems Market by Component Outlook
- 7.4. Hardware
- 7.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 7.5. Software
- 7.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 7.6. Services
- 7.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
- Chapter 8. Clinical Decision Support Systems Market: Regional Estimates & Trend Analysis, By Type, By Application, By Delivery Mode, By Component
- 8.1. Regional Market Share Analysis, 2025 & 2033
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
- 8.5. North America
- 8.5.1. U.S.
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework
- 8.5.1.3. Competitive scenario
- 8.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.2. Canada
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework
- 8.5.2.3. Competitive scenario
- 8.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.3. Mexico
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework
- 8.5.3.3. Competitive scenario
- 8.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6. Europe
- 8.6.1. UK
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework
- 8.6.1.3. Competitive scenario
- 8.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.2. Germany
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.3. France
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory framework
- 8.6.3.3. Competitive scenario
- 8.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.4. Italy
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Regulatory framework
- 8.6.4.3. Competitive scenario
- 8.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.5. Spain
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Regulatory framework
- 8.6.5.3. Competitive scenario
- 8.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.6. Norway
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Regulatory framework
- 8.6.6.3. Competitive scenario
- 8.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.7. Sweden
- 8.6.7.1. Key country dynamics
- 8.6.7.2. Regulatory framework
- 8.6.7.3. Competitive scenario
- 8.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.8. Denmark
- 8.6.8.1. Key country dynamics
- 8.6.8.2. Regulatory framework
- 8.6.8.3. Competitive scenario
- 8.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7. Asia Pacific
- 8.7.1. Japan
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework
- 8.7.1.3. Competitive scenario
- 8.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.2. China
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework
- 8.7.2.3. Competitive scenario
- 8.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.3. India
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory framework
- 8.7.3.3. Competitive scenario
- 8.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.4. Australia
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory framework
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.5. South Korea
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Regulatory framework
- 8.7.5.3. Competitive scenario
- 8.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.6. Singapore
- 8.7.6.1. Key country dynamics
- 8.7.6.2. Regulatory framework
- 8.7.6.3. Competitive scenario
- 8.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8. Latin America
- 8.8.1. Brazil
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Regulatory framework
- 8.8.1.3. Competitive scenario
- 8.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.2. Argentina
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Regulatory framework
- 8.8.2.3. Competitive scenario
- 8.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9. MEA
- 8.9.1. South Africa
- 8.9.1.1. Key country dynamics
- 8.9.1.2. Regulatory framework
- 8.9.1.3. Competitive scenario
- 8.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.2. Saudi Arabia
- 8.9.2.1. Key country dynamics
- 8.9.2.2. Regulatory framework
- 8.9.2.3. Competitive scenario
- 8.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.3. UAE
- 8.9.3.1. Key country dynamics
- 8.9.3.2. Regulatory framework
- 8.9.3.3. Competitive scenario
- 8.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.4. Kuwait
- 8.9.4.1. Key country dynamics
- 8.9.4.2. Regulatory framework
- 8.9.4.3. Competitive scenario
- 8.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Company Market Position Analysis, 2025
- 9.4. Company Market Share Analysis, 2025
- 9.5. Company Profiles/Listing
- 9.5.1. McKesson Corporation
- 9.5.1.1. Company overview
- 9.5.1.2. Financial performance
- 9.5.1.3. Product benchmarking
- 9.5.1.4. Strategic initiatives
- 9.5.2. Oracle
- 9.5.2.1. Company overview
- 9.5.2.2. Financial performance
- 9.5.2.3. Product benchmarking
- 9.5.2.4. Strategic initiatives
- 9.5.3. Siemens Healthineers AG
- 9.5.3.1. Company overview
- 9.5.3.2. Financial performance
- 9.5.3.3. Product benchmarking
- 9.5.3.4. Strategic initiatives
- 9.5.4. Allscripts Healthcare, LLC
- 9.5.4.1. Company overview
- 9.5.4.2. Financial performance
- 9.5.4.3. Product benchmarking
- 9.5.4.4. Strategic initiatives
- 9.5.5. athenahealth, Inc.
- 9.5.5.1. Company overview
- 9.5.5.2. Financial performance
- 9.5.5.3. Product benchmarking
- 9.5.5.4. Strategic initiatives
- 9.5.6. NextGen Healthcare Inc.
- 9.5.6.1. Company overview
- 9.5.6.2. Financial performance
- 9.5.6.3. Product benchmarking
- 9.5.6.4. Strategic initiatives
- 9.5.7. Koninklijke Philips N.V.
- 9.5.7.1. Company overview
- 9.5.7.2. Financial performance
- 9.5.7.3. Product benchmarking
- 9.5.7.4. Strategic initiatives
- 9.5.8. IBM
- 9.5.8.1. Company overview
- 9.5.8.2. Financial performance
- 9.5.8.3. Product benchmarking
- 9.5.8.4. Strategic initiatives
- 9.5.9. Agfa-Gevaert Group
- 9.5.9.1. Company overview
- 9.5.9.2. Financial performance
- 9.5.9.3. Product benchmarking
- 9.5.9.4. Strategic initiatives
- 9.5.10. Wolters Kluwer N.V.
- 9.5.10.1. Company overview
- 9.5.10.2. Financial performance
- 9.5.10.3. Product benchmarking
- 9.5.10.4. Strategic initiatives
- 9.5.11. Becton, Dickinson and Company
- 9.5.11.1. Company overview
- 9.5.11.2. Financial performance
- 9.5.11.3. Product benchmarking
- 9.5.11.4. Strategic initiatives
- 9.5.12. Cabot Technology Solutions
- 9.5.12.1. Company overview
- 9.5.12.2. Financial performance
- 9.5.12.3. Product benchmarking
- 9.5.12.4. Strategic initiatives
- 9.5.13. GE HealthCare
- 9.5.13.1. Company overview
- 9.5.13.2. Financial performance
- 9.5.13.3. Product benchmarking
- 9.5.13.4. Strategic initiatives
- 9.5.14. Nordic
- 9.5.14.1. Company overview
- 9.5.14.2. Financial performance
- 9.5.14.3. Product benchmarking
- 9.5.14.4. Strategic initiatives
- 9.5.15. BeeKeeperAI
- 9.5.15.1. Company overview
- 9.5.15.2. Financial performance
- 9.5.15.3. Product benchmarking
- 9.5.15.4. Strategic initiatives
- 9.5.16. BSCO Industries, Inc.
- 9.5.16.1. Company overview
- 9.5.16.2. Financial performance
- 9.5.16.3. Product benchmarking
- 9.5.16.4. Strategic initiatives
- 9.5.17. Epic Systems Corporation
- 9.5.17.1. Company overview
- 9.5.17.2. Financial performance
- 9.5.17.3. Product benchmarking
- 9.5.17.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
